Marshall Wace
TERN

Marshall Wace’s Terns Pharmaceuticals TERN Stock Holding History

Marshall Wace’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.9M Buy
927,600
+49,017
+6% +$2.01M 0.05% 368
2025
Q4 		$35.5M Buy
+878,583
New +$20.3M 0.03% 445
2025
Q2 		– Sell
-144,644
Closed -$399K – 3168
2025
Q1 		$399K Sell
144,644
-658,692
-82% -$2.69M ﹤0.01% 2166
2024
Q4 		$4.45M Buy
803,336
+698,578
+667% +$4.73M 0.01% 1109
2024
Q3 		$874K Buy
104,758
+78,773
+303% +$648K ﹤0.01% 1699
2024
Q2 		$177K Sell
25,985
-160,024
-86% -$969K ﹤0.01% 2316
2024
Q1 		$1.22M Buy
+186,009
New +$1.21M ﹤0.01% 1575
2023
Q3 		– Sell
-356,726
Closed -$3.12M – 2673
2023
Q2 		$3.12M Buy
356,726
+171,698
+93% +$2M 0.01% 1209
2023
Q1 		$2.19M Buy
185,028
+148,947
+413% +$1.42M ﹤0.01% 1410
2022
Q4 		$367K Buy
+36,081
New +$240K ﹤0.01% 2491

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Marshall Wace's TERN Position: Q1 2026 in Review

Marshall Wace increased its Terns Pharmaceuticals (TERN) stake by 5.6% in Q1 2026, buying an estimated $2.01M and bringing the position to 927,600 shares worth $48.9M. The position accounts for 0.05% of the portfolio, ranked #368.

Marshall Wace first reported a position in TERN in Q4 2022 and has held it in 10 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Marshall Wace held 927,600 shares of Terns Pharmaceuticals worth $48.9M as of Q1 2026.
  • Marshall Wace bought 49,017 Terns Pharmaceuticals shares in Q1 2026, an estimated $2.01M.
  • Terns Pharmaceuticals made up 0.05% of Marshall Wace's portfolio in Q1 2026, its #368 holding.
  • Marshall Wace first reported a position in Terns Pharmaceuticals in Q4 2022 and has held it in 10 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.